Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
| ▸ | CDC42 | P60953 | 3/20 | 0.31 |
| ▸ | RAC1 | P63000 | 3/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | PAK1 | Q13153 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19868415 | 0.83 | CYP3A4 (0.31) | — | |
| SCHEMBL20872606 | 0.83 | FAAH (0.30) | — | |
| SCHEMBL20872459 | 0.80 | MCL1 (0.44) | CDC42RAC1PTGS1PTGS2NPC1 | |
| SCHEMBL6291385 | 0.79 | FAAH (0.31) | — | |
| SCHEMBL9362516 | 0.76 | HSD17B10 (0.37) | — | |
| Bicarbonate SCHEMBL8383478 | 0.76 | FAAH (0.30) | — | |
| SCHEMBL6484479 | 0.75 | L3MBTL1 (0.40) | — | |
| SCHEMBL6409121 | 0.75 | — | — | |
| SCHEMBL3764135 | 0.75 | — | — | |
| SCHEMBL16099787 | 0.74 | MGLL (0.44) | NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11873280-B2 | Cross-linking agent(s) | GL CHEMTEC VISION INC. (CA) | 2024-01-16 | — | — | US | disclosed |
| US-11873280-B2 | Cross-linking agent(s) | GL CHEMTEC VISION INC. (CA) | 2024-01-16 | — | — | US | disclosed |
| US-20210130292-A1 | CROSS-LINKING AGENT(S) | GL CHEMTEC VISION INC. (CA) | 2021-05-06 | — | — | US | disclosed |
| US-10919853-B2 | Cross-linking agent(s) | GL CHEMTEC VISION INC. (CA) | 2021-02-16 | — | — | US | disclosed |
| US-20190210965-A1 | CROSS-LINKING AGENT(S) | GL CHEMTEC VISION INC. (CA) | 2019-07-11 | — | — | US | disclosed |
| WO-2018027311-A1 | CROSS-LINKING AGENT(S) | GL CHEMTEC VISION INC. (CA) | 2018-02-15 | — | — | WO | disclosed |
| US-8119392-B2 | Biocompatible resists | THE UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE (US) | 2012-02-21 | — | — | US | disclosed |
| US-20050014098-A1 | Biocompatible resists | NORTH CAROLINA AT CHARLOTTE, THE UNIVERSITY OF | 2005-01-20 | — | — | US | disclosed |
| WO-2004099373-A2 | BIOCOMPATIBLE RESISTS | UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE (US) | 2004-11-18 | — | — | WO | disclosed |
| CN-1152859-C | Novel N-vinyllactam derivatives and polymers thereof | 现代电子产业株式会社 | 2004-06-09 | — | — | CN | disclosed |
| US-5955606-A | PHOTORESISTS OF POLYVINYLLACTAMS | HYUNDAI ELECTRONICS INDUSTRIES CO., LTD. (KR) | 1999-09-21 | — | — | US | disclosed |
| US-5750680-A | BLOCKED AT 3-POSITION; FOR USE IN MICROLITHOGRAPHY OF SEMICONDUCTORS | HYUNDAI ELECTRONICS INDUSTRIES CO., LTD. (KR) | 1998-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210130292-A1 | CROSS-LINKING AGENT(S) | WASF2, ITK, MACF1 | ACHE 596/4885PTPN1 3132/4885CDC42 559/4885 |
| US-20190210965-A1 | CROSS-LINKING AGENT(S) | WASF2, ITK, MACF1 | ACHE 596/4885PTPN1 3132/4885CDC42 559/4885 |
| US-11873280-B2 | Cross-linking agent(s) | WASF2, ITK, MACF1 | ACHE 596/4885PTPN1 3132/4885CDC42 559/4885 |
| US-10919853-B2 | Cross-linking agent(s) | WASF2, ITK, MACF1 | ACHE 596/4885PTPN1 3132/4885CDC42 559/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.